Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8401 - 8408 of 12085 results
Justice Question Whether EEOC Should Pay $4.7M in Attorney Fees
March 30, 2016| News
Summer Blockbuster: DOL’s Divisive Union “Persuader” Rule Coming to Employers Near You on July 1, 2016
March 29, 2016| Blog| Viewpoint
Paul Dickerson and Tom Burton Emphasize the Importance of Energy Diversity Amidst a Changing Global Energy Landscape
March 29, 2016| Blog| Viewpoint
Post-Senate Vote, Major Food Manufacturers Choose to Label Genetically Engineered Foods
March 29, 2016| Blog| Viewpoint
CMS Seeks Input on Medicare's Value-Based Insurance Design Model
March 29, 2016| Blog| Viewpoint
Four Reasons to File an RCE with a Request to Suspend Processing
March 29, 2016| Blog| Viewpoint
More Money, More Problems? – The Rise of Compensation and Expectations for College Coaches (Employment Matters)
March 28, 2016| Blog| Viewpoint
The Supreme Court’s Tyson Foods Ruling and Employee Class Actions
March 28, 2016| Alert| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|